- Home
- LFCR vs AOMR Comparison
LFCR vs AOMR Comparison
Compare LFCR & AOMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | LFCR | AOMR |
|---|---|---|
| Founded | 1986 | 2018 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 190.9M | 210.5M |
| IPO Year | 1996 | 2019 |
Fundamental Metrics
Financial Performance| Metric | LFCR | AOMR |
|---|---|---|
| Price | $4.39 | $8.97 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 3 | 3 |
| Target Price | $6.00 | ★ $11.08 |
| AVG Volume (30 Days) | ★ 145.6K | 85.2K |
| Earning Date | 05-06-2026 | 05-05-2026 |
| Dividend Yield | N/A | ★ 14.18% |
| EPS Growth | N/A | ★ 53.85 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $557,559,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $5.04 | $1.38 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 6.36 | N/A |
| 52 Week Low | $3.63 | $7.96 |
| 52 Week High | $8.98 | $10.14 |
Technical Indicators
Market Signals| Indicator | LFCR | AOMR |
|---|---|---|
| Relative Strength Index (RSI) | 33.10 | 54.58 |
| Support Level | $4.22 | $8.75 |
| Resistance Level | $5.34 | $9.24 |
| Average True Range (ATR) | 0.26 | 0.17 |
| MACD | -0.04 | -0.02 |
| Stochastic Oscillator | 3.30 | 48.33 |
Price Performance
Historical ComparisonAbout LFCR Lifecore Biomedical Inc.
Lifecore Biomedical Inc is a fully integrated contract development and manufacturing organization (CDMO) that provides services in the development, fill, and finish of complex sterile injectable pharmaceutical products in syringes, vials, and cartridges. The group recognizes revenue in two different product categories, CDMO and HA manufacturing.
About AOMR Angel Oak Mortgage REIT Inc.
Angel Oak Mortgage REIT Inc is a real estate finance company focused on acquiring and investing in first and second lien non-QM loans and other mortgage-related assets in the U.S. mortgage market. Its objective is to generate attractive risk-adjusted returns for its stockholders, through cash distributions and capital appreciation, across interest rate and credit cycles. The company operates in a single operating segment, which is to acquire, invest in, and finance mortgage-related assets.